Haemophilia, 1351-8216

Journal

More filtering options
  1. 2021
  2. Real-world prophylactic usage of recombinant factor VIII Fc in Sweden: A report from the Swedish national registry for bleeding disorders

    Margareta Holmström, Elsa Olsson, Jan Astermark, Malin Axelsson, Anna Olsson, Linda Myrin Westesson, Aletta Falk, Johan Szamosi & Karin Sennfält, 2021 May 13, In: Haemophilia.

    Research output: Contribution to journalLetter

  3. Comparison of single subject and population-based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia A

    Jan Astermark, Anna Olsson, Pierre Chelle, Kinga Täckström, Maria Walger, Maria Magnusson & Alfonso Iorio, 2021 May 9, In: Haemophilia.

    Research output: Contribution to journalArticle

  4. Practical considerations for nonfactor-replacement therapies in the treatment of haemophilia with inhibitors

    Victor Jiménez-Yuste, Günter Auerswald, Gary Benson, Gerry Dolan, Cedric Hermans, Thierry Lambert, Rolf Ljung, Massimo Morfini, Elena Santagostino & Silva Zupančić Šalek, 2021 Mar, In: Haemophilia.

    Research output: Contribution to journalReview article

  5. Bleeding phenotype of patients with moderate haemophilia A and B assessed by thromboelastometry and thrombin generation

    Ragnhild J. Måseide, Erik Berntorp, Vuokko Nummi, Riitta Lassila, Geir E. Tjønnfjord & Pål A. Holme, 2021, In: Haemophilia.

    Research output: Contribution to journalArticle

  6. Collagen remodelling and plasma ascorbic acid levels in patients suspected of inherited bleeding disorders harbouring germline variants in collagen‐related genes

    Marcus Fager Ferrari, Eva Zetterberg, Maria Rossing, Tina Manon‐jensen, Martin Pehrsson, Morten A. Karsdal, Jens Lykkesfeldt & Eva Leinoe, 2021, In: Haemophilia. 27, 1, p. e69-e77

    Research output: Contribution to journalArticle

  7. Haemophilia early arthropathy detection with ultrasound and haemophilia joint health score in the moderate haemophilia (MoHem) study

    Ragnhild J. Måseide, Erik Berntorp, Jan Astermark, Jessica Hansen, Anna Olsson, Maria Bruzelius, Tony Frisk, Magnus Aspdahl, Vuokko Nummi, Geir E. Tjønnfjord & P. Holme, 2021, In: Haemophilia. 27, 2

    Research output: Contribution to journalArticle

  8. Recombinant FVIIa in elective non-orthopaedic surgery of adults with haemophilia and inhibitors: A systematic literature review

    Gerard Dolan, Jan Astermark & Cedric Hermans, 2021, In: Haemophilia.

    Research output: Contribution to journalReview article

  9. The B-Natural study—The outcome of immune tolerance induction therapy in patients with severe haemophilia B

    Jan Astermark, Katharina Holstein, Yasmina L. Abajas, Susan Kearney, Stacy E. Croteau, Riana Liesner, Eva Funding, Christine L. Kempton, Suchitra Acharya, Stefan Lethagen, Petra LeBeau, Joel Bowen, Erik Berntorp & Amy D. Shapiro, 2021, In: Haemophilia.

    Research output: Contribution to journalArticle

  10. Treatment outcomes in persons with severe haemophilia B in the Nordic region: The B-NORD study

    Kristina Kihlberg, Fariba Baghaei, Maria Bruzelius, Eva Funding, Pål Andre Holme, Riitta Lassila, Vuokko Nummi, Susanna Ranta, Mehdi Osooli, Erik Berntorp & Jan Astermark, 2021, In: Haemophilia.

    Research output: Contribution to journalArticle

  11. Validation of factor VIII activity for monitoring standard and extended half-life products and correlation to thrombin generation assays

    Cecilia Augustsson, Eva Norström, Vivian Lind, Myriam Martin, Jan Astermark & Karin Strandberg, 2021, In: Haemophilia.

    Research output: Contribution to journalArticle

  12. 2020
  13. Joint health and treatment modalities in Nordic patients with moderate haemophilia A and B – The MoHem study

    Ragnhild J. Måseide, Erik Berntorp, Jan Astermark, Anna Olsson, Maria Bruzelius, Tony Frisk, Vuokko Nummi, Riitta Lassila, Geir E. Tjønnfjord & Pål A. Holme, 2020 Sep, In: Haemophilia. 26, 5, p. 891-897 7 p.

    Research output: Contribution to journalArticle

  14. Critical appraisal of the International Prophylaxis Study Group magnetic resonance image scale for evaluating haemophilic arthropathy

    Mirkamal Tolend, Haris Majeed, Magdy Soliman, Paulo Daruge, Marcelo Bordalo-Rodrigues, Sergio San Juan Dertkigil, Sridhar Gibikote, Shyamkumar N. Keshava, Jennifer Stimec, Amy Dunn, Ying Jia Li, Victor Blanchette, Björn Lundin & Andrea S. Doria, 2020 Jul, In: Haemophilia. 26, 4, p. 565-574 10 p.

    Research output: Contribution to journalArticle

  15. Registries and databases: A European perspective

    Rolf C R Ljung, 2020 Apr, In: Haemophilia. 26 , Suppl 3, p. 26-28 2 p.

    Research output: Contribution to journalArticle

  16. Achieving the unimaginable: Health equity in haemophilia

    Mark W. Skinner, Diane Nugent, Pam Wilton, Brian O’Mahony, Gerry Dolan, Jamie O’Hara & Erik Berntorp, 2020 Jan, In: Haemophilia. 26, 1, p. 17-24 8 p.

    Research output: Contribution to journalReview article

  17. Genetic screening of children with suspected inherited bleeding disorders

    Nadine Andersson, Maria Rossing, Marcus Fager Ferrari, Migle Gabrielaite, Eva Leinøe, Rolf Ljung, Annika Mårtensson, Eva Norström & Eva Zetterberg, 2020, In: Haemophilia. 26, 2, p. 314-324 11 p.

    Research output: Contribution to journalArticle

  18. 2019
  19. Coagulation factor VIII is vital for increasing global coagulation after physical exercise

    Marcus Ljungkvist, Henric Olofsson, Eva Funding, Erik Berntorp & Eva Zetterberg, 2019, In: Haemophilia. 25, 2, p. e86-e93

    Research output: Contribution to journalArticle

  20. Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram: A Nordic study

    Marcus Ljungkvist, Karin Strandberg, Erik Berntorp, Roza Chaireti, Pål André Holme, Ole Halfdan Larsen, Riitta Lassila, Annukka Jouppila, Timea Szanto & Eva Zetterberg, 2019, In: Haemophilia. 25, 2, p. 334-342

    Research output: Contribution to journalArticle

  21. Joint comorbidities among Swedish carriers of haemophilia: A register-based cohort study over 22 years

    Mehdi Osooli, Sharyne M. Donfield, Katarina Steen Carlsson, Fariba Baghaei, Margareta Holmström, Erik Berntorp & Jan Astermark, 2019, In: Haemophilia. 25, 5, p. 845-850

    Research output: Contribution to journalArticle

  22. Moderate haemophilia in focus

    Erik Berntorp, 2019, In: Haemophilia. 25, 2, p. 187-188

    Research output: Contribution to journalDebate/Note/Editorial

  23. Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies

    Peter Volkers, Kay-Martin Hanschmann, Thierry Calvez, Hervé Chambost, Peter W Collins, Virginie Demiguel, Daniel P Hart, Charles R M Hay, Jenny Goudemand, Rolf Ljung, Ben P Palmer, Elena Santagostino, Ella M van Hardeveld, Marijke van den Berg & Brigitte Keller-Stanislawski, 2019, In: Haemophilia. 25, 3, p. 398-407

    Research output: Contribution to journalArticle

  24. Sports participation and physical activity in adult Dutch and Swedish patients with severe haemophilia: A comparison between intermediate- and high-dose prophylaxis

    Olav Versloot, Erik Berntorp, Pia Petrini, Rolf Ljung, Jan Astermark, Margareta Holmström, Piet de Kleijn & Kathelijn Fischer, 2019, In: Haemophilia. 25, 2, p. 244-251

    Research output: Contribution to journalArticle

  25. 2018
  26. Fifth Åland Island conference on von Willebrand disease

    E. Berntorp, A. Ågren, L. Aledort, M. Blombäck, M. H. Cnossen, S. E. Croteau, M. von Depka, A. B. Federici, A. Goodeve, J. Goudemand, P. M. Mannucci, M. Mourik, P. T. Önundarson, F. Rodeghiero, T. Szántó & J. Windyga, 2018 May 1, In: Haemophilia. 24, p. 5-19 15 p.

    Research output: Contribution to journalArticle

  27. Replacement therapy during surgery in von Willebrand disease needs personalization

    E. Berntorp, 2018 May 1, In: Haemophilia. 24, 3, p. 338-340 3 p.

    Research output: Contribution to journalDebate/Note/Editorial

  28. The role of the laboratory in diagnosis and management of inhibitory antibodies in haemophilia

    K. Strandberg & J. Astermark, 2018 May 1, In: Haemophilia. 24, p. 9-14 6 p.

    Research output: Contribution to journalArticle

  29. Defining extended half-life rFVIII-A critical review of the evidence

    J. Mahlangu, G. Young, C. Hermans, V. Blanchette, E. Berntorp & E. Santagostino, 2018 May, In: Haemophilia. 24, 3, p. 348-358

    Research output: Contribution to journalArticle

  30. Pharmacokinetic modelling and validation of the half-life extension needed to reduce the burden of infusions compared with standard factor VIII

    C. Hermans, J. Mahlangu, J. Booth, H. Schütz, E. Santagostino, G. Young, H. Y. Lee, K. N. Steinitz-Trost, V. Blanchette & E. Berntorp, 2018 May, In: Haemophilia. 24, 3, p. 376-384

    Research output: Contribution to journalArticle

  31. Immune tolerance induction: What have we learned over time?

    H. H. Brackmann, G. C. White, E. Berntorp, T. Andersen & C. Escuriola-Ettingshausen, 2018 Apr 1, In: Haemophilia. 24, p. 3-14 12 p.

    Research output: Contribution to journalReview article

  32. Evaluation of prophylactic therapy in haemophilia with global coagulation tests

    E. Zetterberg, K. Brolin, R. Lindahl, K. Knobe & E. Berntorp, 2018 Jan 1, In: Haemophilia. 24, 1, p. e10-e13

    Research output: Contribution to journalLetter

  33. 2017
  34. Preference-based valuation of treatment attributes in haemophilia A using web survey

    K. Steen Carlsson, E. Andersson & E. Berntorp, 2017 Nov 1, In: Haemophilia. 23, 6, p. 894-903 10 p.

    Research output: Contribution to journalArticle

  35. The impact of clinical practice on the outcome of central venous access devices in children with haemophilia

    Kate Khair, S Ranta, A. Thomas & Karin Lindvall, 2017 Jul 1, In: Haemophilia. 23, 4, p. e276-e281

    Research output: Contribution to journalArticle

  36. Comparative burden of arthropathy in mild haemophilia: a register-based study in Sweden

    M Osooli, S Lövdahl, K Steen Carlsson, K Knobe, F. Baghaei, M Holmström, J Astermark & E Berntorp, 2017 Mar, In: Haemophilia. 23, 2, p. e79-e86

    Research output: Contribution to journalArticle

  37. European retrospective study of real-life haemophilia treatment

    E. Berntorp, G. Dolan, C. Hay, S. Linari, E. Santagostino, A. Tosetto, G. Castaman, Mt Álvarez-Román, R. Parra Lopez, J. Oldenburg, T. Albert, U. Scholz, M. Holmström, J. F. Schved, M. Trossaërt, C. Hermans, A. Boban, C. Ludlam & S. Lethagen, 2017 Jan, In: Haemophilia. 23, 1, p. 105-114

    Research output: Contribution to journalArticle

  38. Anti-factor VIII antibodies in brothers with haemophilia A share similar characteristics

    J. Kahle, A. Orlowski, D. Stichel, J. F. Healey, E. T. Parker, S. M. Donfield, J. Astermark, E. Berntorp, P. Lollar, D. Schwabe & C. Königs, 2017, In: Haemophilia. 23, 2, p. 292-299

    Research output: Contribution to journalArticle

  39. Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B

    K. Kihlberg, K. Strandberg, S. Rosén, R. Ljung & J. Astermark, 2017, In: Haemophilia. 23, 4, p. 620-627

    Research output: Contribution to journalArticle

  40. Low agreement between fresh and frozen-thawed platelet-rich plasma in the calibrated automated thrombogram assay

    M. Ljungkvist, S. Lövdahl, E. Zetterberg & E. Berntorp, 2017, In: Haemophilia. 23, 3, p. e214-e218

    Research output: Contribution to journalArticle

  41. Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits: A two-centre study

    A. Hillarp, A. E. Bowyer, M Ezban, P. Persson & S. Kitchen, 2017, In: Haemophilia. 23, 3, p. 458-465

    Research output: Contribution to journalArticle

  42. Plasma products do not solve the inhibitor problem

    H. M. van den Berg, S. Pipe & R. Ljung, 2017, In: Haemophilia. 23, 3, p. 346-347

    Research output: Contribution to journalDebate/Note/Editorial

  43. The association between health utility and joint status among people with severe haemophilia A: findings from the KAPPA register

    M Osooli, K Steen Carlsson, F Baghaei, M Holmström, S. Rauchensteiner, P A Holme, L Hvitfeldt, J Astermark & E Berntorp, 2017, In: Haemophilia. 23, 3, p. e180-e187

    Research output: Contribution to journalArticle

  44. 2016
  45. Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in Finland

    K. Vepsäläinen, R. Lassila, M. Arola, P. Huttunen, S. Koskinen, R. Ljung, P. Lähteenmäki, M. Möttönen & P. Riikonen, 2016 Sep 1, In: Haemophilia. 22, 5, p. 721-729 9 p.

    Research output: Contribution to journalArticle

  46. Potential biomarkers of haemophilic arthropathy: correlations with compatible additive magnetic resonance imaging scores

    J. Oldenburg, R. Zimmermann, O. Katsarou, E. Zanon, E. Kellermann, B. Lundin & P. Ellinghaus, 2016 Sep 1, In: Haemophilia. 22, 5, p. 760-764 5 p.

    Research output: Contribution to journalArticle

  47. Haemophilia treatment in 2030

    E. Berntorp, 2016 Jul 1, In: Haemophilia. 22, S5, p. 15-19 5 p.

    Research output: Contribution to journalArticle

  48. Phenotype and genotype comparisons in carriers of haemophilia A

    A Olsson, R Ljung, M Hellgren, E Berntorp & F Baghaei, 2016 May, In: Haemophilia. 22, 3, p. 235–237

    Research output: Contribution to journalArticle

  49. Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe

    P. A. Holme, C. Combescure, R. C. Tait, E. Berntorp, S. Rauchensteiner & P. de Moerloose, 2016 Mar 1, In: Haemophilia. 22, 2, p. 248-255 8 p.

    Research output: Contribution to journalArticle

  50. Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxis.

    L A Valentino, S W Pipe, P W Collins, V S Blanchette, Erik Berntorp, K Fischer, B M Ewenstein, M Oh & G Spotts, 2016, In: Haemophilia. 22, 4, p. 514-20

    Research output: Contribution to journalArticle

  51. BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial.

    Rolf Ljung, G Kenet, M E Mancuso, V Kaleva, L Rusen, D Tseneklidou-Stoeter, L A Michaels, A Shah, W Hong & M Maas Enriquez, 2016, In: Haemophilia. 22, 3, p. 354-360

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 Next